Gp Pharm is a finished-dose manufacturer based in Spain. It appears in 120 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with AEMPS (ES), EMA and INFARMED (PT). Its GMP standing is certified by US FDA, AEMPS (ES) and EMA. Its most recent recorded inspection, by US FDA, closed on 21 September 2023 as VAI. Customs aggregates show $7.1M of exports covering 148 molecules to 10 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Sant Quinti de Mediona (Barcelona), United Arab Emirates | Not on file |
| Spain, Spain | 3008345811 |
| Barcelona, Spain | Not on file |
| Sant Quinti De Mediona, Spain | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| AEMPS (ES) | 32 | 1 |
| EMA | 28 | 1 |
| INFARMED (PT) | 21 | None |
| ANMAT (AR) | 17 | None |
| MPA (SE) | 7 | None |
| DIGEMAPS (DO) | 7 | None |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $7.1M | 10 |
| 2024 | Not reported | $8.0M | 12 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Gp Pharm comes back tiered against every other supplier able to file there.
Start for free